D. C. Tormey

498 total citations
11 papers, 369 citations indexed

About

D. C. Tormey is a scholar working on Oncology, Cancer Research and Genetics. According to data from OpenAlex, D. C. Tormey has authored 11 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 5 papers in Cancer Research and 3 papers in Genetics. Recurrent topics in D. C. Tormey's work include Cancer Treatment and Pharmacology (8 papers), Breast Cancer Treatment Studies (4 papers) and Estrogen and related hormone effects (3 papers). D. C. Tormey is often cited by papers focused on Cancer Treatment and Pharmacology (8 papers), Breast Cancer Treatment Studies (4 papers) and Estrogen and related hormone effects (3 papers). D. C. Tormey collaborates with scholars based in United States, South Africa and United Kingdom. D. C. Tormey's co-authors include H. C. Falkson, R Gray, Frank J. Cummings, Janet Wolter, Paul P. Carbone, Geoffrey Falkson, Kennedy W. Gilchrist, John Crowley, T. E. Davis and Pierre R. Band and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Cancer and Preventive Medicine.

In The Last Decade

D. C. Tormey

11 papers receiving 345 citations

Peers

Countries citing papers authored by D. C. Tormey

Since Specialization

Citations

This map shows the geographic impact of D. C. Tormey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. C. Tormey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. C. Tormey more than expected).

Fields of papers citing papers by D. C. Tormey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. C. Tormey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. C. Tormey. The network helps show where D. C. Tormey may publish in the future.

Co-authorship network of co-authors of D. C. Tormey

This figure shows the co-authorship network connecting the top 25 collaborators of D. C. Tormey. A scholar is included among the top collaborators of D. C. Tormey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. C. Tormey. D. C. Tormey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Postchemotherapy Adjuvant Tamoxifen Therapy Beyond Five Years in Patients With Lymph Node-Positive Breast Cancer 1996 ·JNCI Journal of the National Cancer Institute ·D. C. Tormey, R Gray, H. C. Falkson, (unknown)	138
2	Hormonal treatment for metastatic breast cancer. An eastern cooperative oncology group phase III trial comparing aminoglutethimide to tamoxifen 1994 ·Cancer ·(unknown), Janet W. Andersen, D. C. Tormey, Edward G. Mansour, Thomas E. Davis, John Horton, Janet Wolter, Thomas J. Smith, Frank J. Cummings	51
3	Organizing multicenter trials: Lessons from the cooperative oncology groups 1991 ·Preventive Medicine ·Paul P. Carbone, D. C. Tormey	6
4	Adjuvant chemohormonal therapy with cyclophosphamide, methotrexate, 5-fluorouracil, and prednisone (CMFP) or CMFP plus tamoxifen compared with CMF for premenopausal breast cancer patients. An eastern cooperative oncology group trial 1990 ·Cancer ·D. C. Tormey, R Gray, Kennedy W. Gilchrist, (unknown), Paul P. Carbone, Janet Wolter, Judith E. Woll, Frank J. Cummings	63
5	Antiestrogen therapy for breast cancer: current strategies and future prospects. 1988 ·PubMed ·V. Craig Jordan, D. C. Tormey	3
6	A Randomized Trial of Postoperative Five-Versus Three-Drug Chemotherapy After Mastectomy: A Cancer and Leukemia Group B (CALGB) Study 1982 ·Recent results in cancer research ·R B Weiss, D. C. Tormey, (unknown), V. Weinberg, Gerson Lesnick, Michael Perloff, Geoffrey Falkson, Oliver Glidewell	5
7	Dibromodulcitol and Adriamycin ± tamoxifen in advanced breast cancer* 1982 ·American Journal of Clinical Oncology ·D. C. Tormey, Geoffrey Falkson, John Crowley, H. C. Falkson, Joseph G. Voelkel, T. E. Davis	45
8	Relationship between time to treatment failure and survival and between time to response and response duration in metastatic breast cancer. Implications for treatment. 1981 ·PubMed ·D. C. Tormey, R. S. Gelman	10
9	The impact of malnutrition on treatment results in breast cancer. 1981 ·PubMed ·(unknown), (unknown), Pierre R. Band, D. C. Tormey	21
10	Evaluation of adriamycin and dibromodulcitol in metastatic breast carcinoma. 1977 ·PubMed ·D. C. Tormey, Ronald Simon, Geoffrey Falkson, (unknown), Pierre R. Band, (unknown), Johannes Blom	19
11	Preliminary trials with a combination of adriamycin (NSC-123127) and bleomycin (NSC-125066) in adult malignancies. 1974 ·PubMed ·D. C. Tormey, Patrick R. Bergevin, Johannes Blom, W. Jeffrey Petty	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact